Genital Infections and Associated Risk Factors in Women on Contraception Monitored at the Bacteriology and Virology Laboratory of Aristide Le Dantec Hospital

Background: Contraception is a strategy of choice for spacing births but also for avoiding early and unwanted pregnancies. However, through hormonal modification, this contraception constitutes a favorable state for the proliferation in the genital tract of agents responsible for vaginal infections. The objective of this study was to evaluate the prevalence of genital infections in women on contraception followed up at the bacteriology-virology laboratory of Aristide Le Dantec Hospital.

Methods: This is a retrospective descriptive study conducted over a one-year period between January 2019 and December 2020. Microbial assessemnets were performed on genital secretions according to standard bacteriology laboratory procedures. Sociodemographic data and bacteriological examination results obtained were entered using File Maker Pro Advanced (version 16) software. Statistical analyses were performed using SPSS software (version 20).

Results: This research studied 1771 women, of whom 1609 were on contraceptives. The most represented age group was over 40 years (27.06%). The majority of patients were women on oral contraceptives (32.07%). Women with secondary education (31.45%) and women with 1 to 3 children (43.03%) were most often on contraception. The germs most frequently detected in women on contraception were Gardnerella vaginalis (51.78%) and Candida albicans (24.19%) and the use of intrauterine device (IUD) as a means of contraception was statistically associated with vaginal infection (p=0.0004).

Conclusion: This study showed a high frequency of vaginal infections in women on contraception and that the intrauterine device was significantly associated with the occurrence of these infections.

1. Maternal and newborn health. https://www.unicef.org/health/maternal-and-newborn-health (Accessed Juil. 21, 2023).
2. Mortalité maternelle. https://www.who.int/fr/ news-room/fact-sheets/detail/maternal-mortality (Accessed Juil. 21, 2023).
3. Agence Nationale de la Statistique et de la Démographie (ANSD) [Sénégal] et ICF. Enquête continue du sénégal, cinquième phase 2017.https://www.ansd.sn/sites/default/files/2022-11/Rapport%20de%20synthese%20Senegal %202017_1 (Accessed Juil.21,2023).
4. Agence Nationale de la Statistique et de la Démographie du Sénégal (ANSDS) ICF International. Enquête démographique et de Santé continue au Sénégal (EDS-Continue) 2014-2015.https://www.ansd.sn/sites/default/ files/2022-11/EDS%20CONTINUE%202015 %20RAPPORT%20PRELIMINAIRE-1_0.pdf
(Accessed Juil.21, 2023).
5. Jain R, Muralidhar S. Contraceptive methods: needs, options and utilization. J Obstet Gynaecol India 2011; 61(6):626-34.
6. Bradshaw CS, Brotman RM. Making inroads into, benefices improving treatment of bacterial vaginosis-pages, striving for long-term cure. BMC Infect Dis 2015; 15:292.
7. Lillian SB, Brenda B, Suzanne S, et al., Infections vulvo-vaginales. Soins infirmiers en médecine et chirurgie 4 : Fonctions rénale et reproductrice. Ed. du Renouveau Pédagogique 2011; 4(20633):1833.
8. Salinas-Muñaz L, Campos-Fernàndez R, Mercader E, et al. Estrogen receptor-alpha (ESR1) governs the lower female-reproductive tract vulnerability to Candida albicans. Front Immunol 2018; 9:1033.
9. Plus d’un million de cas d’infection sexuellement transmissibles curables surviennent chaque jour. https://www.who.int/fr/news/item/06-06-2019 (Accessed Juil.21, 2023).
10. Stratégie mondiale de lutte contre les infections sexuellement transmissible, 2006 – 2015. https://apps.who.int/iris/handle/10665/ 43772 (Accessed Juil.21,2023).
11. Diallo J. La politique de planification familiale au Sénégal ; approche sanitaire et conflits de norme. Autrepart 2014; 2(70):41-55.
12. Barry NA. Pratique contraceptive chez les femmes porteuses d’une pathologie chronique à propos de 250 cas. Thèse Méd UCAD 2015; N°87.
13. Mogtomo MLK, Njiki AN, Longang AM, et al. Prévalence des germes impliqués dans les infections vaginales chez les femmes camerounaises et facteurs de risque. Int Jn Biol Chem 2016; 10(1):255-68.
14. Bitew A, Abebaw Y, Bekele D, et al. Prevalence of bacterial vaginosis and associated risk factors among women complaining of genital tract infection. Int J Microbiol 2017; 2017:4919404.
15. Denis F, Cattoir V, Martin C, et al. Bactériologie médicale : Technique usuelles. 3e édition, Elsevier Masson 2016; 223-575.
16. Seck MC, Faye B, Ndiaye M, et al. Prévalence de Trichomonas vaginalis et de Candida albicans chez les femmes au laboratoire de l’hôpital militaire de Ouakame, Dakar (Sénégal). Med Afr Noir 2015; 61(1):3-37.
17. Sylla K. Candidose vulvo-vaginale au laboratoire de parasitologie-mycologie du centre hospitalier universitaire de Fann Dakar (Sénégal). Rev. Cames Santé 2017; 5(2):72-43.

Files	XML pdf (322KB)
Issue	Vol 11 No 5-6 (2023)
Section	Original Articles
DOI	https://doi.org/10.18502/jmb.v11i5-6.14357
Keywords
Contraception Gardnerella vagginalis Women IUD Vaginosis.

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Dieng A, Aidara S, Fall A, Diouf N, Ndiaye SM, Tine A, Cisse S, Diagne H, Cisse M, Samb M, Ndiaye S, Diop D, Diallo A, Ndiaye H, Camara M. Genital Infections and Associated Risk Factors in Women on Contraception Monitored at the Bacteriology and Virology Laboratory of Aristide Le Dantec Hospital. J Med Bacteriol. 2023;11(5-6):1-7.

Vancouver

Download Citation